有些功能开发出来，一定要自己用一下！！！
预约中心，竟然没有检索功能！一个一个找？？？还没有名字排序，我佛了！！！！
药研社
Published by:
Shanghai Mudi Biotech Co
Description
===临研工具百宝箱===
面向临床试验专业人员提供CTCAE4.03，CTCAE5.0，RECIST1.1，常见AE对照，异常解读，TNM分期，中心机构信息，伦理上会日期，找试验，找研究者等工具以及行业资讯和数据，专注于临床试验和医药研发行业，为临床试验行业人工作提效；“抢单”功能，让您在碎片时间，获取更多专业收益；更有“临研圈”社区，打造临研人的专属成长交流社区。
===主要功能===
【临研圈】供临研人交流学习，成长互助
【中心】机构中心伦理信息流程要求随时查询
【工具】10余款行业工具，助力提升工作提效
【抢单】碎片时间更有价值，获得更多个人收益
===联系我们===
微信关注：临研圈（Mutrial）
商务合作：[email protected]
官方网站：www.yaoyanshe.com
Hide
Show More...
面向临床试验专业人员提供CTCAE4.03，CTCAE5.0，RECIST1.1，常见AE对照，异常解读，TNM分期，中心机构信息，伦理上会日期，找试验，找研究者等工具以及行业资讯和数据，专注于临床试验和医药研发行业，为临床试验行业人工作提效；“抢单”功能，让您在碎片时间，获取更多专业收益；更有“临研圈”社区，打造临研人的专属成长交流社区。
===主要功能===
【临研圈】供临研人交流学习，成长互助
【中心】机构中心伦理信息流程要求随时查询
【工具】10余款行业工具，助力提升工作提效
【抢单】碎片时间更有价值，获得更多个人收益
===联系我们===
微信关注：临研圈（Mutrial）
商务合作：[email protected]
官方网站：www.yaoyanshe.com
Screenshots
药研社 FAQ
-
Is 药研社 free?
Yes, 药研社 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 药研社 legit?
🤔 The 药研社 app's quality is mixed. Some users are satisfied, while others report issues. Consider reading individual reviews for more context.
Thanks for the vote -
How much does 药研社 cost?
药研社 is free.
-
What is 药研社 revenue?
To get estimated revenue of 药研社 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Switzerland yet.
Ratings History
药研社 Reviews
ipad要是看视频能全屏就好了
ipad只有一半界面
Bug修复
苹果有些链接点不了 ，比如新版gcp答题大挑战等
临研好工具
临研好工具
神器
recist也上了 ctcae也有 tnm分期也有 肿瘤项目必备
第一次为app写评论
我是一名大三护理系学生，未来的就业目标是crc，在某一天浏览crc招聘时发现了这个app，很感兴趣，遂下载，里面的内容完全是我想要的，还有crc的课程学习，很感动也很受用！我会努力认真的学习，掌握更多crc的知识，利用临床实习的间歇考取gcp证书，希望一年后能有机会去药研社工作！
真的好用！
信息整理得真不错！
很好用的软件，crx必备
功能强大，使用方便，提高了我不少工作效率，推荐使用
很不错
加油
CRA必备神器呀
大爱机构数据库，真心给力！
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
255
|
药研社 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
中肿掌上医院APP
|
Unlock
|
Unlock
|
0
|
|
3 weeks ago | |
用药助手 - 实用临床决策工具
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
医脉通-医生的临床决策好帮手
医学资讯传递，病例实战宝典
|
Unlock
|
Unlock
|
0
|
|
1 month ago | |
梅斯医学 - 医路相伴，成就大医
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
CSCO
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
良医汇-肿瘤医生
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
掌上微试 - 让临床研究更简单
|
Unlock
|
Unlock
|
0
|
|
1 week ago | |
药智数据-医药人的掌上数据库
药智网官方APP-专注医药数据查询
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
O-Trial Plus
|
Unlock
|
Unlock
|
0
|
|
4 months ago | |
前海自助理赔
N/A
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
药研社 Installs
Last 30 days
药研社 Revenue
Last 30 days药研社 Revenue and Downloads
Gain valuable insights into 药研社 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Shanghai Mudi Biotech Co
- Languages
- English, Chinese
- Recent release
- 5.3.3 (2 months ago )
- Released on
- Dec 19, 2015 (9 years ago )
- Also available in
- China , United States , Malaysia , Mexico , Philippines , Peru , New Zealand , Norway , Netherlands , Nigeria , Poland , Lebanon , Kazakhstan , Kuwait , South Korea , Japan , Italy , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.